Pharmacological inhibition of COX-2 was found to reduce collagen deposition and tumor growth in the MMTV-PyMT or MMTV-PyMT/Col1a1 mouse models [21], and invasion during mammary gland involution [21, 22]. Here, PTGS2 is linked to neoplasm.